Fundamental analysis · SEC EDGAR · TTM through 31/03/2026
PODD · Nasdaq · Healthcare
Fundamental quality
88
out of 100
Source: SEC EDGAR · TTM through 31/03/2026
The score combines growth, profitability and financial strength. Here its growth weighs in its favor, while its profitability drags it down the most.
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2021 | $1,099M | $17M | -$180M | — |
| 2022 | $1,305M | $5M | -$4M | — |
| 2023 | $1,697M | $206M | $70M | — |
| 2024 | $2,072M | $418M | $305M | — |
| 2025 | $2,708M | $247M | $378M | — |
Between 2021 and 2025, revenue went from $1,099M to $2,708M (+146%) and net income went from $17M to $247M (+1371%).
Annual figures in U.S. dollars per SEC filings. Net debt is total debt minus cash.
Is Insulet Corp a profitable company?
Yes. Insulet Corp shows a net margin of 10.4% and an ROE of 23.2%, a sign of a profitable business.
Does Insulet Corp have a lot of debt?
Not particularly. Its net debt is 0.88 times its EBITDA, a low level.
Is Insulet Corp growing?
Its revenue has grown 27.9% annualized in recent years and its earnings per share 254.9%.
Does Insulet Corp generate cash?
Yes. It converts about 14.3% of its revenue into free cash flow.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
Is Insulet Corp cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Brokers you can use to invest in U.S. and European stocks.
The serious investor's standard →
Popular in the U.S. →
Other analyses
NVIDIA (NVDA) · Microsoft (MSFT) · Apple (AAPL) · Alphabet (Google) (GOOGL) · Amazon (AMZN) · Meta Platforms (META) · see more →